Showing Results for
- Academic Journals (1)
Search Results
- 1
Academic Journals
- 1
- Search Terms:
- 1From: BMC Cancer. (Vol. 10) Peer-ReviewedBackground Sunitinib is an oral, multitargeted tyrosine kinase inhibitor that has been approved for the treatment of metastatic renal cell carcinoma. Although the majority of sunitinib-treated patients receive a...